Evidence map›Paper›PMID 42721956›Full record

ArticleThe American journal of tropical medicine and hygiene2026

Low Generation Culex quinquefasciatus from Texas and Culex pipiens from New Jersey Are Incompetent Vectors for Oropouche Virus.

Erik Turner, Nicole Foley, Casey Parker-Crockett, Linda Kothera, Emily Davis, Matylda Lally, Cassandra Durden, Joan L Kenney

Abstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Erik TurnerDivision of Vector Borne Disease, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.
Nicole FoleyDivision of Vector Borne Disease, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.
Casey Parker-CrockettDivision of Vector Borne Disease, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.
Linda KotheraDivision of Vector Borne Disease, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.
Emily DavisDivision of Vector Borne Disease, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.
Matylda LallyDivision of Vector Borne Disease, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.
Cassandra DurdenDivision of Vector Borne Disease, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.
Joan L KenneyDivision of Vector Borne Disease, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During the 2024 Oropouche virus (OROV) outbreak in South America, mosquito surveillance led to the identification of pools of Culex quinquefasciatus infected with the virus. Because of the outbreak strain's status as a novel reassortment and the novel sequela discovered during this outbreak, concerns arose about Culex species as potential vectors in the continental United States. To assess the risk posed by Cx. quinquefasciatus and the closely related species Culex pipiens, the vector competence of mosquitoes reared from eggs collected in Dallas, TX, and New Jersey was examined. Three replicates of an infectious bloodmeal were offered to Cx. quinquefasciatus at generations F2, F4, and F9, resulting in 0/305 individuals with midgut infections. One infectious bloodmeal was offered to Cx. pipiens at generation F4, with 0/120 resulting midgut infections. These data, which align with other recent publications, indicate that United States populations of Cx. quinquefasciatus and Cx. pipiens are not competent vectors of the outbreak strain of OROV.

Identifiers

PMID42721956
PMCPMC13590957

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.